arrow_back Civic Audit
Share share

Drug Price Transparency: Mandatory Disclosure of Costs in Consumer Ads.

This Act mandates that direct-to-consumer advertisements for prescription drugs must clearly disclose the Wholesale Acquisition Cost (WAC) for a 30-day supply. This change aims to empower citizens to better estimate their out-of-pocket expenses, particularly those with high-deductible health plans. The goal is to foster informed decision-making and increase price competition in the pharmaceutical market.
Key points
Drug manufacturers must display the Wholesale Acquisition Cost (WAC) for a 30-day supply in all consumer advertisements.
This provides consumers with crucial cost information before receiving a prescription, helping them manage personal finances.
Drugs with a WAC below $35 for a 30-day supply are exempt from this disclosure requirement.
Non-compliance with the new rules may result in civil monetary penalties of up to $100,000 per violation.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 118_S_1250
Sponsor: Sen. Durbin, Richard J. [D-IL]
Process start date: 2023-04-20